LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

W. Zeijlemaker, R. Meijer, A. Kelder, J. Carbaat-Ham, Y. Oussoren-brockhoff, S. Snel, D. Veldhuizen, W. Scholten, J. Maertens, D. Breems, T. Pabst, M. Manz, V. Van der Velden, J. Slomp, P. Valk, J. Cloos, B. Lowenberg, G. Ossenkoppele, G. J. Schuurhuis

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)7-8
JournalHaematologica
Volume102
Publication statusPublished - 26 Jun 2017

Cite this

Zeijlemaker, W. ; Meijer, R. ; Kelder, A. ; Carbaat-Ham, J. ; Oussoren-brockhoff, Y. ; Snel, S. ; Veldhuizen, D. ; Scholten, W. ; Maertens, J. ; Breems, D. ; Pabst, T. ; Manz, M. ; Van der Velden, V. ; Slomp, J. ; Valk, P. ; Cloos, J. ; Lowenberg, B. ; Ossenkoppele, G. ; Schuurhuis, G. J. / LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY. In: Haematologica. 2017 ; Vol. 102. pp. 7-8.
@article{08b5a729d7024e0f832380bff0bf497f,
title = "LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY",
author = "W. Zeijlemaker and R. Meijer and A. Kelder and J. Carbaat-Ham and Y. Oussoren-brockhoff and S. Snel and D. Veldhuizen and W. Scholten and J. Maertens and D. Breems and T. Pabst and M. Manz and {Van der Velden}, V. and J. Slomp and P. Valk and J. Cloos and B. Lowenberg and G. Ossenkoppele and Schuurhuis, {G. J.}",
year = "2017",
month = "6",
day = "26",
language = "English",
volume = "102",
pages = "7--8",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",

}

Zeijlemaker, W, Meijer, R, Kelder, A, Carbaat-Ham, J, Oussoren-brockhoff, Y, Snel, S, Veldhuizen, D, Scholten, W, Maertens, J, Breems, D, Pabst, T, Manz, M, Van der Velden, V, Slomp, J, Valk, P, Cloos, J, Lowenberg, B, Ossenkoppele, G & Schuurhuis, GJ 2017, 'LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY' Haematologica, vol. 102, pp. 7-8.

LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY. / Zeijlemaker, W.; Meijer, R.; Kelder, A.; Carbaat-Ham, J.; Oussoren-brockhoff, Y.; Snel, S.; Veldhuizen, D.; Scholten, W.; Maertens, J.; Breems, D.; Pabst, T.; Manz, M.; Van der Velden, V.; Slomp, J.; Valk, P.; Cloos, J.; Lowenberg, B.; Ossenkoppele, G.; Schuurhuis, G. J.

In: Haematologica, Vol. 102, 26.06.2017, p. 7-8.

Research output: Contribution to journalMeeting AbstractAcademic

TY - JOUR

T1 - LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

AU - Zeijlemaker, W.

AU - Meijer, R.

AU - Kelder, A.

AU - Carbaat-Ham, J.

AU - Oussoren-brockhoff, Y.

AU - Snel, S.

AU - Veldhuizen, D.

AU - Scholten, W.

AU - Maertens, J.

AU - Breems, D.

AU - Pabst, T.

AU - Manz, M.

AU - Van der Velden, V.

AU - Slomp, J.

AU - Valk, P.

AU - Cloos, J.

AU - Lowenberg, B.

AU - Ossenkoppele, G.

AU - Schuurhuis, G. J.

PY - 2017/6/26

Y1 - 2017/6/26

M3 - Meeting Abstract

VL - 102

SP - 7

EP - 8

JO - Haematologica

JF - Haematologica

SN - 0390-6078

ER -